Virinchi to acquire Bristlecone Hospitals business for Rs 100 Cr via postal ballot

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

VIRINCHI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹15.40

prior close

₹16.06

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+3.6% vs market

Software Products peers, median of 36sector+0.9%+4.1% vs sector

On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 4.1 pts more than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.5

15m

+0.6

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9+1.4+3.6+0.9+4.1

Next day

+3.9+1.5+2.4+0.6+3.3

+3.2+0.5+2.7+0.2+3.0

+1.6+1.1+0.4+0.5+1.1

+0.1+0.7-0.5-0.3+0.4

+0.6-0.4+1.1-2.2+2.8

+2.5+0.5+1.9-2.3+4.8

15d

-0.1+0.1-0.1-2.8+2.7

+1.3+3.5-2.2-4.0+5.3

-7.7+5.8-13.5-3.7-4.0

-15.6+2.4-18.0-1.5-14.0

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 36Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Virinchi Ltd seeks shareholder approval via postal ballot to acquire the Primary and Secondary Healthcare business (Bristlecone Hospitals brand) from its material subsidiary Virinchi Health Care Pvt Ltd for Rs 100 Crores on a slump sale basis. The deal aims to build an AI-first healthcare platform. Effective April 1, 2026. It is a material related party transaction with promoters barred from voting. E-voting runs July 12 to August 10, 2026.

Likely market impact

Brings hospital business into listed entity to build AI-focused healthcare platform; Rs 100 Cr deal among related parties needs shareholder approval.